TrialAnnals of the rheumatic diseases2013

A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study.

Won Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.